Journal
CANCER
Volume 129, Issue 15, Pages 2290-2293Publisher
WILEY
DOI: 10.1002/cncr.34825
Keywords
-
Categories
Ask authors/readers for more resources
The prognostic significance of primary cutaneous melanoma tumor mitotic rate (TMR) has been of interest in the clinical field worldwide for many years. Is there a way to utilize the findings from Patuzzo et al. and other studies to enhance the classification and staging of melanoma, as well as develop clinical tools that incorporate TMR for improved risk and prognostic assessment?
The prognostic significance of primary cutaneous melanoma tumor mitotic rate (TMR) has been of worldwide clinical interest for decades. Is there a path forward to build on the contributions from the report by Patuzzo et al. and other studies to refine the classification and staging of melanoma and to develop clinical tools to improve risk and prognostic assessment that include TMR to inform decision-making?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available